Skip to content

Biomarkers of Ovarian Reserve and Correlation With IVF Treatments

Predictors of Ovarian Response in Women Undergoing Ovarian Stimulation for IVF

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02442895
Enrollment
236
Registered
2015-05-13
Start date
2014-02-28
Completion date
2015-02-28
Last updated
2015-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy, Ovarian

Keywords

mature oocytes, antral follicles count, follicle stimulating hormone, antimullerian hormone

Brief summary

Retrospective study to evaluate the correlation between AFC, FSHb, AMH and IVF outcomes of 347 cycles performed with three different protocols.

Detailed description

347 IVF cycles (236 patients) analyzed for a retrospective study to evaluate the correlation between the biomarkers of ovarian reserve (antral follicles count, antimullerian hormone, basal follicle stimulating hormone) and number of oocytes and mature oocytes (MII) retrieved during the pick up. For the stimulation were used three different protocols: long luteal, antagonist with daily administration of gonadotropins and antagonist with depot administration of gonadotropins.

Interventions

None listed

Sponsors

U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* women with primary or secondary infertility underwent ovarian stimulation for in vitro fertilization.

Exclusion criteria

* women who underwent ovarian stimulation for cryopreservation in the presence of neoplastic disease.

Design outcomes

Primary

MeasureTime frameDescription
number of total and mature (MII) oocytes10 monthsthe number of total and mature (MII) oocytes retrieved during the pick up.

Secondary

MeasureTime frameDescription
duration of stimulation10 monthsthe number of days since the administration of rFSH o corifollitropina alfa until the administration of hCG
ovarian sensitivity index or OSI10 monthsOSI was calculated dividing the total administered FSH dose by the number of retrieved oocytes
pregnancy rate10 monthsthe number of positive pregnancy tests with the evidence of an embyo with cardiac activity.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026